Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Accepts healthy volunteers Results available

A Study to Evaluate the Safety, Tolerability, and Immunogenicity of Two Lots of V114 in Healthy Infants (V114-008)

ClinicalTrials.gov ID: NCT02987972

Public ClinicalTrials.gov record NCT02987972. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 5:29 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II, Double-Blind, Randomized, Multicenter Trial to Evaluate the Safety, Tolerability, and Immunogenicity of V114 Compared to Prevnar 13™ in Healthy Infants

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study is designed to evaluate the safety, tolerability, and immunogenicity of two different lots of V114 in healthy infants 6 to 12 weeks (\>=42 days to \<=90 days) of age. The primary hypothesis of the study is that the proportion of participants receiving V114 who have serotype specific IgG \>=0.35 mcg/mL for each of pneumococcal serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F at 1 month after Dose 3 is non-inferior to that for recipients of Prevnar 13™.

Study identification

NCT ID
NCT02987972
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Merck Sharp & Dohme LLC
Industry
Enrollment
1,051 participants

Conditions and interventions

Interventions

Biological

Eligibility (public fields only)

Age range
6 Weeks to 12 Weeks
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 20, 2017
Primary completion
Oct 3, 2018
Completion
Oct 3, 2018
Last update posted
Oct 22, 2019

2017 – 2018

United States locations

U.S. sites
30
U.S. states
16
U.S. cities
30
Facility City State ZIP Site status
Birmingham Pediatric Research ( Site 0043) Birmingham Alabama 35205
Southeastern Pediatric Associates, P.A. ( Site 0079) Dothan Alabama 36305
Children's Clinic of Jonesboro, PA ( Site 0054) Jonesboro Arkansas 72401
Premier Health Research Center, LLC ( Site 0035) Downey California 90241
Sherif Khamis MD, Inc. ( Site 0044) Palmdale California 93550
Kaiser Permanente - Roseville ( Site 0045) Roseville California 95661
Kaiser Permanente Clinical Trial - Sacramento ( Site 0076) Sacramento California 95815
Kentucky Pediatric/Adult Research Inc ( Site 0037) Bardstown Kentucky 40004
University of Louisville: Pediatric Clinical Trials Unit ( Site 0049) Louisville Kentucky 40202
ACC Pediatric Research ( Site 0039) Haughton Louisiana 71037
Woburn Pediatric Associates ( Site 0046) Woburn Massachusetts 01801
Dundee Clinic ( Site 0063) Omaha Nebraska 68132
Child Health Care Associates ( Site 0064) East Syracuse New York 13057
State University of New York Upstate Medical University ( Site 0065) Syracuse New York 13210
Pediatric Associates of Mt. Carmel, Inc. ( Site 0052) Cincinnati Ohio 45245
Senders Pediatrics ( Site 0058) Cleveland Ohio 44121
Ohio Pediatric Research Association ( Site 0060) Dayton Ohio 45414
Pediatric Medical Associates ( Site 0059) East Norriton Pennsylvania 19401
Kid's Way Pediatrics ( Site 0036) Hermitage Pennsylvania 16148
Thomas Jefferson University ( Site 0067) Philadelphia Pennsylvania 19107
Coastal Pediatric Research ( Site 0070) Charleston South Carolina 29414
Holston Medical Group [Kingsport, TN] ( Site 0048) Kingsport Tennessee 37660
University of Texas Medical Branch at Galveston ( Site 0056) Galveston Texas 77555
University of Texas Medical Branch at Galveston ( Site 0068) League City Texas 77573
Wee Care Pediatrics ( Site 0042) Layton Utah 84041
Cottonwood Pediatrics ( Site 0041) Murray Utah 84107
Copperview Medical Center ( Site 0062) South Jordan Utah 84095
Pediatric Research of Charlottesville, LLC ( Site 0066) Charlottesville Virginia 22902
Huguenot Pediatrics ( Site 0057) Midlothian Virginia 23113
Family Health Care of Ellensburg ( Site 0077) Ellensburg Washington 98926

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 19 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02987972, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 22, 2019 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02987972 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →